The Novartis Decision: Is the Big Win for Indian Pharma Bad News for Investment?

• 
  

  By Krista Mahr
  The rejection of Novartis’ patent application for a drug it developed more than a decade ago has been hailed by health care advocates. But it may spell bad news for New Delhi’s attempts …

Read more: http://world.time.com#ixzz2PMIz8bNr